Class IITerminatedD-1039-2016
Drug recall · June 29, 2016
tabcin ACTIVE M.R. Capsules recall
Why: CGMP Deviations
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
tabcin ACTIVE M.R. Capsules, 12-count box , UPC 7501008485057
- Lots / codes
Lot # 224TS; Exp. 02/17
- Quantity
- 42 boxes (504 capsules)
- Company
- Profarma Distributors LLC, Columbus, OH
- Distribution
- Nationwide
- Initiated
- May 11, 2016 · Voluntary: Firm initiated
- Classified
- June 17, 2016
- Reported
- June 29, 2016
- Ended
- January 24, 2017
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Class IITerminatedJun 29, 2016tabcin NOCHEProfarma Distributors LLC · D-1040-2016Class IITerminatedJun 29, 2016VERMOX Tablets 100 mgProfarma Distributors LLC · D-1041-2016Class IITerminatedJun 29, 2016VERMOX Tablets 500 mgProfarma Distributors LLC · D-1042-2016Class IITerminatedJun 29, 20161% Clotrimazol creamProfarma Distributors LLC · D-1043-2016
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.